-
1
-
-
84881012522
-
Sole trisomy 8 in patients (pts) with de novo Acute Myeloid Leukemia (AML) is associated with age-independent poor outcome that is modified by molecular markers and with unique gene- and microrna (miR)-signatures: A Cancer and Leukemia Group B (CALGB) study
-
Becker H, Maharry K, Radmacher MD, Margeson D, Mrozek K, et al. (2010) Sole trisomy 8 in patients (pts) with de novo Acute Myeloid Leukemia (AML) is associated with age-independent poor outcome that is modified by molecular markers and with unique gene- and microrna (miR)-signatures: A Cancer and Leukemia Group B (CALGB) study. Blood 116:255-5.
-
(2010)
Blood
, vol.116
, pp. 255-255
-
-
Becker, H.1
Maharry, K.2
Radmacher, M.D.3
Margeson, D.4
Mrozek, K.5
-
2
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from cancer and leukemia group B (CALGB 8461)
-
DOI 10.1182/blood-2002-03-0772
-
Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, et al. (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100:4325-36. (Pubitemid 35429670)
-
(2002)
Blood
, vol.100
, Issue.13
, pp. 4325-4336
-
-
Byrd, J.C.1
Mrozek, K.2
Dodge, R.K.3
Carroll, A.J.4
Edwards, C.G.5
Arthur, D.C.6
Pettenati, M.J.7
Patil, S.R.8
Rao, K.W.9
Watson, M.S.10
Koduru, P.R.K.11
Moore, J.O.12
Stone, R.M.13
Mayer, R.J.14
Feldman, E.J.15
Davey, F.R.16
Schiffer, C.A.17
Larson, R.A.18
Bloomfield, C.D.19
-
3
-
-
77955914238
-
Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
-
Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, et al. (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354-65.
-
(2010)
Blood
, vol.116
, pp. 354-365
-
-
Grimwade, D.1
Hills, R.K.2
Moorman, A.V.3
Walker, H.4
Chatters, S.5
-
4
-
-
0032188805
-
The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
-
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, et al. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92:2322-33. (Pubitemid 28452973)
-
(1998)
Blood
, vol.92
, Issue.7
, pp. 2322-2333
-
-
Grimwade, D.1
Walker, H.2
Oliver, F.3
Wheatley, K.4
Harrison, C.5
Harrison, G.6
Rees, J.7
Hann, I.8
Stevens, R.9
Burnett, A.10
Goldstone, A.11
-
5
-
-
0034672269
-
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
-
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, et al. (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96:4075-83.
-
(2000)
Blood
, vol.96
, pp. 4075-4083
-
-
Slovak, M.L.1
Kopecky, K.J.2
Cassileth, P.A.3
Harrington, D.H.4
Theil, K.S.5
-
6
-
-
77449159028
-
Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet
-
Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, et al. (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453-74.
-
(2010)
Blood
, vol.115
, pp. 453-474
-
-
Dohner, H.1
Estey, E.H.2
Amadori, S.3
Appelbaum, F.R.4
Buchner, T.5
-
7
-
-
78149294040
-
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Whitman SP, Maharry K, Radmacher MD, Becker H, Mrozek K, et al. (2010) FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116:3622-6.
-
(2010)
Blood
, vol.116
, pp. 3622-3626
-
-
Whitman, S.P.1
Maharry, K.2
Radmacher, M.D.3
Becker, H.4
Mrozek, K.5
-
8
-
-
0037097716
-
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis
-
DOI 10.1182/blood.V99.12.4326
-
Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, et al. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326-35. (Pubitemid 34627197)
-
(2002)
Blood
, vol.99
, Issue.12
, pp. 4326-4335
-
-
Thiede, C.1
Steudel, C.2
Mohr, B.3
Schaich, M.4
Schakel, U.5
Platzbecker, U.6
Wermke, M.7
Bornhauser, M.8
Ritter, M.9
Neubauer, A.10
Ehninger, G.11
Illmer, T.12
-
9
-
-
77449140390
-
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: A Cancer and Leukemia Group B study
-
Becker H, Marcucci G, Maharry K, Radmacher MD, Mrozek K, et al. (2010) Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol 28:596-604.
-
(2010)
J Clin Oncol
, vol.28
, pp. 596-604
-
-
Becker, H.1
Marcucci, G.2
Maharry, K.3
Radmacher, M.D.4
Mrozek, K.5
-
10
-
-
19944427850
-
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype
-
DOI 10.1056/NEJMoa041974
-
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, et al. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352:254-66. (Pubitemid 40110814)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.3
, pp. 254-266
-
-
Falini, B.1
Mecucci, C.2
Tiacci, E.3
Alcalay, M.4
Rosati, R.5
Pasqualucci, L.6
La, S.R.7
Diverio, D.8
Colombo, E.9
Santucci, A.10
Bigerna, B.11
Pacini, R.12
Pucciarini, A.13
Liso, A.14
Vignetti, M.15
Fazi, P.16
Meani, N.17
Pettirossi, V.18
Saglio, G.19
Mandelli, F.20
Lo-Coco, F.21
Pelicci, P.-G.22
Martelli, M.F.23
more..
-
11
-
-
55549103713
-
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A Cancer and Leukemia Group B Study
-
Marcucci G, Maharry K, Radmacher MD, Mrozek K, Vukosavljevic T, et al. (2008) Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 26:5078-87.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5078-5087
-
-
Marcucci, G.1
Maharry, K.2
Radmacher, M.D.3
Mrozek, K.4
Vukosavljevic, T.5
-
12
-
-
79952122978
-
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity
-
Taskesen E, Bullinger L, Corbacioglu A, Sanders MA, Erpelinck CA, et al. (2011) Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood 117:2469-75.
-
(2011)
Blood
, vol.117
, pp. 2469-2475
-
-
Taskesen, E.1
Bullinger, L.2
Corbacioglu, A.3
Sanders, M.A.4
Erpelinck, C.A.5
-
13
-
-
78649906060
-
DNMT3A Mutations in Acute Myeloid Leukemia
-
Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, et al. (2010) DNMT3A Mutations in Acute Myeloid Leukemia. New England Journal of Medicine 363:2424-33.
-
(2010)
New England Journal of Medicine
, vol.363
, pp. 2424-2433
-
-
Ley, T.J.1
Ding, L.2
Walter, M.J.3
McLellan, M.D.4
Lamprecht, T.5
-
14
-
-
79953176952
-
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
-
Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, et al. (2011) Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics 43:309-U351.
-
(2011)
Nature Genetics
, vol.43
-
-
Yan, X.J.1
Xu, J.2
Gu, Z.H.3
Pan, C.M.4
Lu, G.5
-
15
-
-
77954089584
-
Array-based genomic resequencing of human leukemia
-
Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, et al. (2010) Array-based genomic resequencing of human leukemia. Oncogene 29:3723-31.
-
(2010)
Oncogene
, vol.29
, pp. 3723-3731
-
-
Yamashita, Y.1
Yuan, J.2
Suetake, I.3
Suzuki, H.4
Ishikawa, Y.5
-
16
-
-
70149093912
-
Recurring mutations found by sequencing an acute myeloid leukemia genome
-
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058-66.
-
(2009)
N Engl J Med
, vol.361
, pp. 1058-1066
-
-
Mardis, E.R.1
Ding, L.2
Dooling, D.J.3
Larson, D.E.4
McLellan, M.D.5
-
17
-
-
77952536841
-
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrozek K, et al. (2010) IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 28:2348-55.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2348-2355
-
-
Marcucci, G.1
Maharry, K.2
Wu, Y.Z.3
Radmacher, M.D.4
Mrozek, K.5
-
18
-
-
84859742518
-
Molecular genetics of acute myeloid leukemia: Clinical implications and opportunities for integrating genomics into clinical practice
-
Abdel-Wahab O (2012) Molecular genetics of acute myeloid leukemia: clinical implications and opportunities for integrating genomics into clinical practice. Hematology 17:S39-S42.
-
(2012)
Hematology
, vol.17
-
-
Abdel-Wahab, O.1
-
19
-
-
66249137734
-
Mutation in TET2 in myeloid cancers
-
Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, et al. (2009) Mutation in TET2 in myeloid cancers. N Engl J Med 360:2289-301.
-
(2009)
N Engl J Med
, vol.360
, pp. 2289-2301
-
-
Delhommeau, F.1
Dupont, S.2
Della Valle, V.3
James, C.4
Trannoy, S.5
-
20
-
-
84863393263
-
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
-
Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun ZX, et al. (2012) Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia. New England Journal of Medicine 366: 1079-89.
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 1079-1089
-
-
Patel, J.P.1
Gonen, M.2
Figueroa, M.E.3
Fernandez, H.4
Sun, Z.X.5
-
21
-
-
84862502902
-
Mutant DNMT3A: A marker of poor prognosis in acute myeloid leukemia
-
Ribeiro AFT, Pratcorona M, Erpelinck-Verschueren C, Rockova V, Sanders M, et al. (2012) Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 119:5824-31.
-
(2012)
Blood
, vol.119
, pp. 5824-5831
-
-
Ribeiro, A.F.T.1
Pratcorona, M.2
Erpelinck-Verschueren, C.3
Rockova, V.4
Sanders, M.5
-
22
-
-
84863116398
-
Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia
-
Marcucci G, Metzeler KH, Schwind S, Becker H, Maharry K, et al. (2012) Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia. Journal of Clinical Oncology 30:742-50.
-
(2012)
Journal of Clinical Oncology
, vol.30
, pp. 742-750
-
-
Marcucci, G.1
Metzeler, K.H.2
Schwind, S.3
Becker, H.4
Maharry, K.5
-
23
-
-
79960735923
-
Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
-
Thol F, Damm F, Ludeking A, Winschel C, Wagner K, et al. (2011) Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia. Journal of Clinical Oncology 29:2889-96.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 2889-2896
-
-
Thol, F.1
Damm, F.2
Ludeking, A.3
Winschel, C.4
Wagner, K.5
-
24
-
-
84862909358
-
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
-
Hou HA, Kuo YY, Liu CY, Chou WC, Lee MC, et al. (2012) DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood 119:559-68.
-
(2012)
Blood
, vol.119
, pp. 559-568
-
-
Hou, H.A.1
Kuo, Y.Y.2
Liu, C.Y.3
Chou, W.C.4
Lee, M.C.5
-
25
-
-
84855853131
-
Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia
-
Markova J, Michkova P, Burckova K, Brezinova J, Michalova K, et al. (2012) Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. European Journal of Haematology 88:128-35.
-
(2012)
European Journal of Haematology
, vol.88
, pp. 128-135
-
-
Markova, J.1
Michkova, P.2
Burckova, K.3
Brezinova, J.4
Michalova, K.5
-
26
-
-
84881051116
-
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: Results of the AML Study Group (AMLSG)
-
Gaidzik VI, Schlenk RF, Paschka P, Stölzle A, Späth D, et al. (2013) Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood 121: 4769-77.
-
(2013)
Blood
, vol.121
, pp. 4769-4777
-
-
Gaidzik, V.I.1
Schlenk, R.F.2
Paschka, P.3
Stölzle, A.4
Späth, D.5
-
27
-
-
13644257725
-
-
Available: Accessed 2013 Jun 23
-
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. Available: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed 2013 Jun 23.
-
(2012)
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses
-
-
Wells, G.A.1
Shea, B.2
O'Connell, D.3
Peterson, J.4
Welch, V.5
-
28
-
-
1542753559
-
Revised Recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
-
DOI 10.1200/JCO.2003.04.036
-
Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, et al. (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 21:4642-9. (Pubitemid 46594039)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.24
, pp. 4642-4649
-
-
Cheson, B.D.1
Bennett, J.M.2
Kopecky, K.J.3
Buchner, T.4
Willman, C.L.5
Estey, E.H.6
Schiffer, C.A.7
Doehner, H.8
Tallman, M.S.9
Lister, T.A.10
LoCocco, F.11
Willemze, R.12
Biondi, A.13
Hiddemann, W.14
Larson, R.A.15
Lowenberg, B.16
Sanz, M.A.17
Head, D.R.18
Ohno, R.19
Bloomfield, C.D.20
more..
-
29
-
-
34547450763
-
Practical methods for incorporating summary time-to-event data into meta-analysis
-
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16.
-
(2007)
Trials
, vol.8
, pp. 16
-
-
Tierney, J.F.1
Stewart, L.A.2
Ghersi, D.3
Burdett, S.4
Sydes, M.R.5
-
30
-
-
0032583387
-
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
-
DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::A
-
Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-34. (Pubitemid 28562978)
-
(1998)
Statistics in Medicine
, vol.17
, Issue.24
, pp. 2815-2834
-
-
Parmar, M.K.B.1
Torri, V.2
Stewart, L.3
-
31
-
-
0022992740
-
Meta-analysis in clinical trials
-
DOI 10.1016/0197-2456(86)90046-2
-
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-88. (Pubitemid 17189972)
-
(1986)
Controlled Clinical Trials
, vol.7
, Issue.3
, pp. 177-188
-
-
DerSimonian, R.1
Laird, N.2
-
32
-
-
77549087054
-
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
-
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735-42.
-
(2010)
Lancet
, vol.375
, pp. 735-742
-
-
Sattar, N.1
Preiss, D.2
Murray, H.M.3
Welsh, P.4
Buckley, B.M.5
-
34
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-101.
-
(1994)
Biometrics
, vol.50
, pp. 1088-1101
-
-
Begg, C.B.1
Mazumdar, M.2
-
35
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-34. (Pubitemid 27387172)
-
(1997)
British Medical Journal
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Smith, G.D.2
Schneider, M.3
Minder, C.4
-
36
-
-
48249154815
-
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry
-
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61:991-6.
-
(2008)
J Clin Epidemiol
, vol.61
, pp. 991-996
-
-
Peters, J.L.1
Sutton, A.J.2
Jones, D.R.3
Abrams, K.R.4
Rushton, L.5
-
37
-
-
69949093866
-
Novel methods to deal with publication biases: Secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications
-
Moreno SG, Sutton AJ, Turner EH, Abrams KR, Cooper NJ, et al. (2009) Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ 339:b2981.
-
(2009)
BMJ
, vol.339
-
-
Moreno, S.G.1
Sutton, A.J.2
Turner, E.H.3
Abrams, K.R.4
Cooper, N.J.5
-
38
-
-
0033934949
-
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
-
Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-63. (Pubitemid 30422636)
-
(2000)
Biometrics
, vol.56
, Issue.2
, pp. 455-463
-
-
Duval, S.1
Tweedie, R.2
-
40
-
-
84903300929
-
Hematopoietic stem cell transplantation (HSCT) benefits the survival of acute myeloid leukemia (AML) patients with IDH1, NRAS and DNMT3A mutations
-
Xu Y, Yang Z, Tian H, Qiu H, Sun A, et al. (2012) Hematopoietic stem cell transplantation (HSCT) benefits the survival of acute myeloid leukemia (AML) patients with IDH1, NRAS and DNMT3A mutations. Blood 120.
-
(2012)
Blood
, pp. 120
-
-
Xu, Y.1
Yang, Z.2
Tian, H.3
Qiu, H.4
Sun, A.5
-
41
-
-
81555228423
-
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
-
Shen Y, Zhu YM, Fan X, Shi JY, Wang QR, et al. (2011) Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 118:5593-603.
-
(2011)
Blood
, vol.118
, pp. 5593-5603
-
-
Shen, Y.1
Zhu, Y.M.2
Fan, X.3
Shi, J.Y.4
Wang, Q.R.5
-
42
-
-
84862007674
-
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: A study by the Acute Leukemia French Association
-
Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, et al. (2012) Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia 26:1247-54.
-
(2012)
Leukemia
, vol.26
, pp. 1247-1254
-
-
Renneville, A.1
Boissel, N.2
Nibourel, O.3
Berthon, C.4
Helevaut, N.5
-
43
-
-
84873570255
-
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: A SWOG report
-
Ostronoff F, Othus M, Ho PA, Kutny M, Geraghty DE, et al. (2013) Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report. Leukemia 27:238-41.
-
(2013)
Leukemia
, vol.27
, pp. 238-241
-
-
Ostronoff, F.1
Othus, M.2
Ho, P.A.3
Kutny, M.4
Geraghty, D.E.5
-
44
-
-
84886804684
-
DNMT3A mutation is a poor prognosis biomarker in AML: Results of a meta-analysis of 4500 AML patients
-
Shivarov V, Gueorguieva R, Stoimenov A, Tiu R (2013) DNMT3A mutation is a poor prognosis biomarker in AML: Results of a meta-analysis of 4500 AML patients. Leukemia Research 37:1445-50.
-
(2013)
Leukemia Research
, vol.37
, pp. 1445-1450
-
-
Shivarov, V.1
Gueorguieva, R.2
Stoimenov, A.3
Tiu, R.4
|